JP Stock MarketDetailed Quotes

4502 Takeda Pharmaceutical

Watchlist
  • 4135.0
  • -12.0-0.29%
20min DelayMarket Closed Dec 13 15:30 JST
6.58TMarket Cap45.36P/E (Static)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Company Profile

Symbol4502
Company NameTakeda Pharmaceutical
Founded1925-01-29
MarketTSE Prime
Employees49281
Fiscal Year Ends03-31
Address1-1, Nihonbashi-Honcho 2-Chome Chuo-ku
Zip Code540-8645
Phone06-6204-2111
Websitewww.takeda.com

Company Executives

  • Name
  • Position
  • Salary
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --
Heat List
JP
Overall
Symbol
Price
% Chg

No Data